These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ascending lower limb phlebography: comparison of ioversol and iothalamate meglumine. Wilson AJ; Murphy WA; Destouet JM; Gilula LA; Hardy DC; Monsees B; Totty WG Can Assoc Radiol J; 1989 Jun; 40(3):142-4. PubMed ID: 2660958 [TBL] [Abstract][Full Text] [Related]
3. A double blind clinical study comparing the safety, tolerance and efficacy of ioversol 240 and iohexol 240 (Omnipaque 240) in ascending venography. Wilkins RA; Spinks BC Clin Radiol; 1990 Apr; 41(4):268-71. PubMed ID: 2187651 [TBL] [Abstract][Full Text] [Related]
4. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials. Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194 [TBL] [Abstract][Full Text] [Related]
9. Thrombosis following phlebography with high-osmolar and low-osmolar contrast media. Eliasen B; Hørup A; Jensen AR Eur J Radiol; 1983 May; 3(2):97-8. PubMed ID: 6347689 [TBL] [Abstract][Full Text] [Related]
10. Ioversol for intravenous urography: a comparison study. Kaufman AJ; Concepcion R; Kirchner FK; McDougal WS; Winfield AC Urol Radiol; 1990; 12(1):56-60. PubMed ID: 2333674 [TBL] [Abstract][Full Text] [Related]
11. Ioversol. Double-blind study of a new low osmolar contrast agent for peripheral and visceral arteriography. Grassi CJ; Bettmann MA; Finkelstein J; Reagan K Invest Radiol; 1989 Feb; 24(2):133-7. PubMed ID: 2917833 [TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind trial of ioversol and iopamidol in contrast-enhanced computed body tomography. Sage MR; Evill CA; Fon GT Invest Radiol; 1989 Jun; 24 Suppl 1():S39-41. PubMed ID: 2687194 [TBL] [Abstract][Full Text] [Related]
13. Discomfort assessment in peripheral angiography: randomized clinical trial of Iodixanol 270 versus Ioversol 320 in diabetics with critical limb ischemia. Palena LM; Sacco ZD; Brigato C; Sultato E; Barra D; Candeo A; Manzi M Catheter Cardiovasc Interv; 2014 Nov; 84(6):1019-25. PubMed ID: 24478190 [TBL] [Abstract][Full Text] [Related]
14. Hexabrix (ioxaglate), a new low osmolality contrast agent for lumbar epidural double-catheter venography. Meijenhorst GC; de Bruin JN Neuroradiology; 1980 Aug; 20(1):29-32. PubMed ID: 6999377 [TBL] [Abstract][Full Text] [Related]
15. A double-blind comparative study of the tolerance of sodium and meglumine ioxaglate (Hexabrix) with meglumine iothalamate (Conray) in ascending phlebography of the leg. Thomas ML; Walters HL; Briggs GM Australas Radiol; 1982 Nov; 26(3):288-90. PubMed ID: 7165617 [No Abstract] [Full Text] [Related]
16. Computed body tomography with a new nonionic contrast agent. Comparison of ioversol with sodium/meglumine diatrizoate. McClennan BL; Heiken JP; Lee JK; James MA Invest Radiol; 1989 Jun; 24 Suppl 1():S35-8. PubMed ID: 2687193 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of two iodinated contrast media containing 20% iodine in lower-limb phlebography: ioxaglate versus a conventional product. Trigaux JP; de Fays R; de Fays F Br J Radiol; 1985 Mar; 58(687):203-5. PubMed ID: 3904894 [TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetics of ioversol in healthy volunteers. Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391 [TBL] [Abstract][Full Text] [Related]
19. Clinical experience with ioversol for angiography. Bettmann MA Invest Radiol; 1989 Jun; 24 Suppl 1():S61-6. PubMed ID: 2687199 [TBL] [Abstract][Full Text] [Related]
20. Efficacy, safety, and tolerability of ioversol in intra-arterial digital subtraction angiography. Miller FJ; Pollei SR; Osborn AG Invest Radiol; 1989 Jun; 24 Suppl 1():S52-4. PubMed ID: 2687197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]